Mayne Pharma | MYX - Operating Profit

Stock Price
2.52
Daily Change
-0.01 -0.40%
Monthly
-10.00%
Yearly
-65.10%
Q1 Forecast
2.59

Mayne Pharma reported AUD-3.3M in Operating Profit for its fiscal semester ending in June of 2024.





Operating Profit Change Date
Ansell USD 58.65M 19.15M Jun/2024
Avita Medical AUD -11.15M 1.19M Jun/2025
Cochlear AUD 125.55M 149.05M Jun/2025
CSL USD 666M 1.31B Jun/2025
Healius AUD -22.6M 47.5M Dec/2024
Integral Diagnostics AUD 19.28M 73.95M Jun/2024
Medical Developments International AUD -480K 662K Jun/2025
Nanosonics AUD 5.3M 3.4M Jun/2025
Polynovo AUD 513K 902K Jun/2024
Ramsay Health Care AUD 537.2M 337.2M Jun/2025
ResMed USD 500.3M 37.95M Dec/2025
Sigma Healthcare AUD 809K 13.76M Dec/2024
Sonic Healthcare AUD 435.76M 193.66M Dec/2024
Telix Pharmaceuticals AUD 8.04M 3.21M Dec/2025